The Effect of Exposure to Perfluorooctanoic Acid during Pregnancy on Myelin Density of Corpus Callosum of Newborn Rat

Document Type : Original Article (s)

Authors

1 MSc Students, Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associate Professor, Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Disruption of myelination process due to exposure to perfluorooctanoic acid (PFOA) can lead to movement disorders. In the present study, the effects of exposure to PFOA during pregnancy on myelin degradation in brain of newborn rat were investigated.Methods: Fertile Wistar rats were randomly divided into five groups of control, sham, and three groups receiving PFOA at doses of 1, 5, and 10 mg/kg body weight. At the end of the study, the brains of 20-day-old neonatal rats were removed and examined using loxal fast blue and immunohistochemical staining. Finally, the data were analyzed using SPSS software. Findings: The mean myelin density in the group receiving PFOA at a dose of 10 mg/kg was significantly lower than the other groups (P < 0.050).Conclusion: The results showed that exposure to PFOA during pregnancy can lead to disruption of myelin production process; so, it is recommended to avoid exposure to toxic agents such as PFOA during pregnancy.

Keywords

References

  1. Ghasemi N. Therapeutic effects of adipose derived mesenchymal stem cells on remyelination process in inflammatory demyelinating diseases. Histol Histopathol 2015; 2(1): 1-7.
  2. Kalman B, Lublin FD. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system. Curr Neurol Neurosci Rep 2001; 1(3): 249-56.
  3. European Food Safety Authority (EFSA). Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts Scientific Opinion of the Panel on Contaminants in the Food chain. EFSA Journal 2008; 6(7): 653.
  4. Goosey E, Harrad S. Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices. Environ Int 2011; 37(1): 86-92.
  5. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010; 118(8): 1100-8.
  6. Jian JM, Guo Y, Zeng L, Liang-Ying L, Lu X, Wang F, et al. Global distribution of perfluorochemicals (PFCs) in potential human exposure source-A review. Environ Int 2017; 108: 51-62.
  7. Loccisano AE, Longnecker MP, Campbell JL, Andersen ME, Clewell HJ. Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. J Toxicol Environ Health A 2013; 76(1): 25-57.
  8. Brede E, Wilhelm M, Goen T, Muller J, Rauchfuss K, Kraft M, et al. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 2010; 213(3): 217-23.
  9. Seals R, Bartell SM, Steenland K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ Health Perspect 2011; 119(1): 119-24.
  10. Johansson N, Fredriksson A, Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008; 29(1): 160-9.
  11. Avila J, Lucas JJ, Perez M, Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev 2004; 84(2): 361-84.
  12. Yuan Z, Zhang J, Zhao B, Miao Z, Wu X. Effects of perfluorooctanoic acid on neural genes expression and neuronal morphology in the planarian Dugesia japonica. Chem Ecol 2016; 32(6): 575-82.
  13. Chen Y, Zhou L, Xu J, Zhang L, Li M, Xie X, et al. Maternal exposure to perfluorooctanoic acid inhibits luteal function via oxidative stress and apoptosis in pregnant mice. Reprod Toxicol 2017; 69: 159-66.
  14. Bagheri E, Marandi SM, Ghasemi N. Evaluation of
  15. curcumin effects on improvement of muscle strength,prevention of oligodendrocytes and myelin damage in brain, in ananimal model of multiple sclersosis (MS). Sci J Kurdistan Univ Med Sci 2018; 23(5): 55-64. [In Persian].
  16. Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ. Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect 2008; 116(6): 716-22.
  17. Webster GM, Venners SA, Mattman A, Martin JW. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Environ Res 2014; 133: 338-47.
  18. Dewitt J. Immunopathogenesis in autism: Regulatory T Cells and autoimmunity in neurodevelopment.
  19. Greenville, NC: East Carolina University; 2011.
  20. Zhu Y, Qin XD, Zeng XW, Paul G, Morawska L, Su MW, et al. Associations of serum perfluoroalkyl acid levels with T-helper cell-specific cytokines in children: By gender and asthma status. Sci Total Environ 2016; 559: 166-73.
  21. Tang J, Lu X, Chen F, Ye X, Zhou D, Yuan J, et al. Effects of perfluorooctanoic acid on the associated genes expression of autophagy signaling pathway of carassius auratus lymphocytes in vitro. Front Physiol 2018; 9: 1748.
  22. Steenland K, Zhao L, Winquist A, Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect 2013; 121(8): 900-5.

Files

History

  • Receive Date: 15 May 2021
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics